Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase III trial of salmeterol/fluticasone dry powder inhaler for adult bronchial asthma
CTR20192141Phase 3Completed
- Sponsor
- Omni Pharmaceutical
- Start
- Oct 2019
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of salmeterol + fluticasone in asthma, sponsored by Omni Pharmaceutical. Started Oct 2019; status: completed.
02
Drugs
salmeterol + fluticasone
03
Conditions
asthma
Beyond the preview
Go deeper on CTR20192141.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20192141.